(Q40355020)

19 September 2017

Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells (English)

1 reference

19 September 2017

1 reference

5

Sanchez-Ramos J

1 reference

19 September 2017

Vesely BA

1

1 reference

19 September 2017

Alli AA

2

1 reference

19 September 2017

Song SJ

3

1 reference

19 September 2017

Gower WR Jr

4

1 reference

19 September 2017

Vesely DL

6

1 reference

19 September 2017

1 November 2005

1 reference

European Journal of Clinical Investigation

19 September 2017

1 reference

19 September 2017

35

1 reference

19 September 2017

11

1 reference

19 September 2017

700-710

1 reference

Four peptides decrease the number of human pancreatic adenocarcinoma cells

19 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Novel therapeutic approach for cancer using four cardiovascular hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Four peptide hormones decrease the number of human breast adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Five cardiac hormones decrease the number of human small-cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

C-type natriuretic peptide in vascular physiology and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Comparative Histopathologic, Histochemical, Electron Microscopic and Tissue Culture Studies of Bronchial Carcinoids and Oat Cell Carcinomas of Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Signal transduction: activation of the guanylate cyclase-cyclic guanosine-3'-5' monophosphate system by hormones and free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01569.X

10.1111/J.1365-2362.2005.01569.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference